Pierre Sayad

Pierre Sayad currently serves as the Chief Medical Officer at Fennec Pharmaceuticals Inc. since October 2024 and is also the Co-Founder and President of mQOL, a role held since October 2021. Previously, Pierre was the Chief Operating Officer at Zephyr Labz from September 2023 to November 2024 and the Senior Vice President, Head of Global Medical Affairs at CTI BioPharma from May 2022 to September 2023. Additionally, Pierre held the position of Senior Vice President, Head of US Medical Affairs at Oncopeptides, Inc. (U.S.) from May 2021 to May 2022. Pierre holds a Ph.D. in Psychoneuroimmunology (PNI) from Loma Linda University and has completed education at Harvard Business School.